Health and Healthcare

Amgen : AMGN

All Amgen Articles

704 Articles

Chris Lange | Oct 12, 2015 at 8:20 AM EDT

Short Sellers Increase Bets in Major Biotechs

The September 30 short interest data have been compared with the previous figures, and short interest increased in most of…

Lee Jackson | Oct 9, 2015 at 10:05 AM EDT

UBS Loves These 3 Top Biotech Stock Leaders Into Q3 Earnings

Given the massive beat-down in the sector, if these companies surpass earnings expectations, the upside could be sizable.

Jon C. Ogg | Sep 29, 2015 at 11:25 AM EDT

Independent Research Sees 3 Top Health and Biotech Stocks as Oversold

Independent research firm Argus has reviews of three of health care picks from its own Focus List in which it…

Chris Lange | Sep 26, 2015 at 9:25 AM EDT

How the Top Biotechs Handled the Valuation Shock

24/7 Wall St. has taken a look at some of the largest biotech companies and highlighted the damage that a…

Chris Lange | Sep 25, 2015 at 8:05 AM EDT

Short Sellers Increase Bets in Major Biotech

The September 15 short interest data have been compared with the previous figures, and short interest in these selected stocks…

Chris Lange | Sep 16, 2015 at 1:20 PM EDT

Fitch: Gradual Conversion Begins as First Biosimilar Hits US Market

According to Fitch Ratings, biosimilars are beginning to take share from their reference biologics. This is seen in the debut…

Chris Lange | Sep 16, 2015 at 11:05 AM EDT

Meet the Newest Biotech Collaboration: Amgen and Xencor

Amgen and Xencor have entered into a research and license agreement to develop and commercialize novel therapeutics in the areas…

Chris Lange | Sep 11, 2015 at 8:05 AM EDT

Short Sellers Increase Bets in Major Biotechs

The short interest data are out for the August 31 settlement date. Short interest in the selected biotech stocks increased…

Jon C. Ogg | Sep 8, 2015 at 9:10 AM EDT

Top Analyst Upgrades and Downgrades: Amgen, Dow, Fitbit, Office Depot, SanDisk, Wells Fargo, Yum and Many More

Tuesday’s top analyst upgrades, downgrades and initiations include Amgen, Dow Chemical, Fitbit, Office Depot, SanDisk, Wells Fargo and Yum! Brands.

Chris Lange | Aug 28, 2015 at 10:25 AM EDT

How Amgen Can Disrupt the Market for Cholesterol Drugs

Amgen has the potential to disrupt the market for cholesterol drugs with the newest addition to its drug portfolio.

Chris Lange | Aug 26, 2015 at 8:55 AM EDT

Short Sellers Become More Focused in Major Biotechs

The short interest data are out for the August 14 settlement date. Biotech companies are considered a riskier group of…

Chris Lange | Aug 12, 2015 at 8:55 AM EDT

Short Sellers Run for Cover From Major Biotechs

The short interest data are out for the July 31 settlement date, and overall, short interest in the selected biotech…

Chris Lange | Aug 6, 2015 at 2:20 PM EDT

5 Big FDA Decisions Expected in August

24/7 Wall St. has collected several big FDA decisions coming up on the calendar for the month of August and…

Chris Lange | Aug 3, 2015 at 11:25 AM EDT

Independent Research Firm Sees Higher Upside in Amgen

According to Argus, second-quarter earnings, along with a strong pipeline and general outlook, have positioned Amgen to take the market…

Paul Ausick | Jul 30, 2015 at 4:26 PM EDT

Amgen Earnings Point to New 52-Week High

ThinkstockAmgen Corp. (NASDAQ: AMGN) reported fiscal second quarter 2015 earnings Thursday afternoon after equity markets had closed. The biotech firm…

1 … 24 25 26 27 28 … 47

Amgen : AMGN

All Amgen Articles

Short Sellers Increase Bets in Major Biotechs

UBS Loves These 3 Top Biotech Stock Leaders Into Q3 Earnings

Independent Research Sees 3 Top Health and Biotech Stocks as Oversold

How the Top Biotechs Handled the Valuation Shock

Short Sellers Increase Bets in Major Biotech

Fitch: Gradual Conversion Begins as First Biosimilar Hits US Market

Meet the Newest Biotech Collaboration: Amgen and Xencor

Short Sellers Increase Bets in Major Biotechs

Top Analyst Upgrades and Downgrades: Amgen, Dow, Fitbit, Office Depot, SanDisk, Wells Fargo, Yum and Many More

How Amgen Can Disrupt the Market for Cholesterol Drugs

Short Sellers Become More Focused in Major Biotechs

Short Sellers Run for Cover From Major Biotechs

5 Big FDA Decisions Expected in August

Independent Research Firm Sees Higher Upside in Amgen

Amgen Earnings Point to New 52-Week High

Google vs Apple: Which of the 2 Biggest AI Stocks Is the Better Buy Right Now?

The 20% Tax Credit Developers Use to Flip Historic Buildings and How You Can Claim It

Your RV Qualifies for the Same Mortgage Interest Deduction as a House, but Most Owners Never Claim It

The 20% Tax Credit Developers Use to Flip Historic Buildings and How You Can Claim It

Your RV Qualifies for the Same Mortgage Interest Deduction as a House, but Most Owners Never Claim It

Google vs Apple: Which of the 2 Biggest AI Stocks Is the Better Buy Right Now?

The 20% Tax Credit Developers Use to Flip Historic Buildings and How You Can Claim It

Amgen : AMGN

All Amgen Articles

Short Sellers Increase Bets in Major Biotechs

UBS Loves These 3 Top Biotech Stock Leaders Into Q3 Earnings

Independent Research Sees 3 Top Health and Biotech Stocks as Oversold

How the Top Biotechs Handled the Valuation Shock

Short Sellers Increase Bets in Major Biotech

Fitch: Gradual Conversion Begins as First Biosimilar Hits US Market

Meet the Newest Biotech Collaboration: Amgen and Xencor

Short Sellers Increase Bets in Major Biotechs

Top Analyst Upgrades and Downgrades: Amgen, Dow, Fitbit, Office Depot, SanDisk, Wells Fargo, Yum and Many More

How Amgen Can Disrupt the Market for Cholesterol Drugs

Short Sellers Become More Focused in Major Biotechs

Short Sellers Run for Cover From Major Biotechs

5 Big FDA Decisions Expected in August

Independent Research Firm Sees Higher Upside in Amgen

Amgen Earnings Point to New 52-Week High

Google vs Apple: Which of the 2 Biggest AI Stocks Is the Better Buy Right Now?

The 20% Tax Credit Developers Use to Flip Historic Buildings and How You Can Claim It

Your RV Qualifies for the Same Mortgage Interest Deduction as a House, but Most Owners Never Claim It

Featured Reads

The 20% Tax Credit Developers Use to Flip Historic Buildings and How You Can Claim It

Your RV Qualifies for the Same Mortgage Interest Deduction as a House, but Most Owners Never Claim It